| Cohance Lifesciences Ltd |
Q2 FY26 net profit down 51% YoY; EBITDA margin shrank to 12.6% due to investment and integration costs. |
| Alembic Pharmaceuticals Ltd |
Received US FDA approval for its ANDA for Dexlansoprazole; market size around $285 mn. |
| PG Electroplast Ltd |
Through subsidiary PG Technoplast, to set up a ₹1,000 cr manufacturing facility on a 50-acre site in Sri City, Tirupati. |
| Tata Steel Ltd |
Q2 FY26 revenue rose 10% QoQ to ₹58,689 cr; margin improvement driven by higher Indian volumes and cost efficiencies. |
| Ashok Leyland Ltd |
Q2 revenue ₹9,588 cr (+9.3% YoY); EBITDA ₹1,162 cr (+14.2% YoY); margin 12.1% (+50 bps); exports surged 45% YoY on strong GCC, Africa & SAARC demand. |